A Multifaceted Intervention on Reducing Immunization Errors
NCT06745635 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2025-02-11
Summary
The goal of this trial is to reduce the general error related to vaccines and immunizations (composited on secondary endpoint), after 11 moths of folow-up after cluster randomization and stepped wedge on primary care on brazilian public health.
The main questions it aims to answer are:
1. To evaluate the effectiveness of a multifaceted intervention in vaccination rooms in reducing vaccination errors.
2. To describe the rate of adverse events following immunization (AEFI) and the associated factors.
Conditions
- Vaccines
- Vaccines Adverse Reaction
- Vaccine Practice
Interventions
- OTHER
-
Usual Care
Usual care for immunizations.
- OTHER
-
Multifaceted intervention
The multifaceted quality improvement intervention includes: video-based training on vaccine management in SUS, an optimized Cold Chain Manual schema, technical documents on proper vaccine handling and immunization schedules, and checklists for managing post-vaccination errors and corrective procedures. Videos will focus on six key points (right person, vaccine, dose, time, route, and documentation), with each lasting about 2 minutes and accessible on-demand. The Cold Chain schema will cover storage, monitoring, transport, conservation, and handling, with checklists for each category. Standardized technical documents will align with video themes, ensuring protocol adherence. An error identification and management schema will address issues like improper vaccine administration, cold chain violations, and incorrect dosages. This schema will be reviewed by staff and made available in health units.
Sponsors & Collaborators
-
Ministry of Health, Brazil
collaborator OTHER_GOV -
Hospital Israelita Albert Einstein
lead OTHER
Principal Investigators
-
Henrique A Fonseca, ScD, PhD · Hospital Albert Einstein
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-07-03
- Primary Completion
- 2026-07-31
- Completion
- 2026-12-30
Countries
- Brazil
Study Locations
More Related Trials
-
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
NCT05933512 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)
NCT00985153 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines
NCT03368495 ·Status: COMPLETED ·Phase: PHASE4
-
An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine
NCT04747821 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Immunization Quality Improvement Dissemination Study
NCT02432430 ·Status: COMPLETED ·Phase: NA
-
ETEC Logistics Trial (TREK)
NCT00516659 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People
NCT05683561 ·Status: UNKNOWN ·Phase: PHASE3
-
A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults
NCT04668339 ·Status: TERMINATED ·Phase: PHASE2
-
Vaccinations and People With Disabilities
NCT05749419 ·Status: RECRUITING
-
ProQuad® Intramuscular vs Subcutaneous
NCT00402831 ·Status: COMPLETED ·Phase: PHASE3
-
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity
NCT04894435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized
NCT05016934 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
NCT04816669 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study
NCT06373510 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19
NCT04780035 ·Status: COMPLETED ·Phase: PHASE3
-
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
NCT01086709 ·Status: COMPLETED
-
To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children
NCT02164110 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021
NCT04728347 ·Status: TERMINATED ·Phase: PHASE2
-
Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers
NCT06068569 ·Status: UNKNOWN ·Phase: PHASE3
-
Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)
NCT03807843 ·Status: COMPLETED ·Phase: PHASE2
-
A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection
NCT04639466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Recombinant Hepatitis E Vaccine
NCT01014845 ·Status: COMPLETED ·Phase: PHASE3
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)
NCT06068556 ·Status: UNKNOWN ·Phase: PHASE3